Intraoperative EABR for Decision Making
Launched by CHRISTOPH ARNOLDNER · Nov 16, 2018
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a specific test called eABR (electrically Evoked Auditory Brainstem Response) can help doctors decide the best approach for patients who need surgery to remove a vestibular schwannoma (a type of tumor on the nerve that helps with balance) and also want to get a cochlear implant to improve their hearing. The researchers want to see if the results of this eABR test during surgery can predict how well patients will hear after the surgery.
If you are between 18 and 99 years old, and you are planning to have surgery for vestibular schwannoma while also considering a cochlear implant for better hearing, you may be eligible to participate in this trial. It's important to know that this study is currently looking for participants. If you decide to join, you will undergo the usual surgical procedures, and the eABR test will be performed during your operation. Your participation could help improve understanding of hearing rehabilitation after this type of surgery, potentially benefiting future patients as well.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients between 18 and 99 years undergoing translabyrinthine vestibular schwannoma resection
- • Patients wanted hearing rehabilitation with a cochlear implant
- Exclusion Criteria:
- • patients who do not want to be part of the study
About Christoph Arnoldner
Christoph Arnoldner is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and innovation. With a focus on enhancing patient outcomes, he leads initiatives that prioritize rigorous scientific methodologies and ethical standards in clinical trials. His expertise encompasses a broad range of therapeutic areas, ensuring that each study is designed to generate meaningful data that contributes to the development of safe and effective treatments. Christoph’s collaborative approach fosters partnerships with healthcare professionals, regulatory bodies, and research institutions, driving progress in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vienna, , Austria
Patients applied
Trial Officials
Christoph Arnoldner, MD
Principal Investigator
MUW, Allgemeines Krankenhaus
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials